Novo Nordisk AS (XTER:NOV)
€ 101.36 0.84 (0.84%) Market Cap: 451.12 Bil Enterprise Value: 448.72 Bil PE Ratio: 35.72 PB Ratio: 27.97 GF Score: 91/100

Novo Nordisk A/S Annual Shareholders Meeting Transcript

Mar 25, 2021 / 01:00PM GMT
Release Date Price: €28.58 (+0.18%)
Helge Lund;S;Independent Chairman of the Board
Novo Nordisk A

/-

Good afternoon, and warmly welcome to Novo Nordisk's 2021 Annual General Meeting. My name is Helge Lund, and I'm the Chair of the Board of Directors of Novo Nordisk. And due to the COVID-19 restrictions, I'm calling in from my home country, Norway.

And let me start out by wishing that you all are safe and well. We had, of course, hoped for the COVID-19 restrictions to have been a thing of the past in 2021, but we still need to be careful and to have precautionary measures in place, why this year's general meeting is fully virtual.

So a warm welcome to all, and thank you for joining us online. Please note that this broadcast is available both in English and in Danish, just choose your preferred language. Allow me to take a minute to reflect on the year that has passed. And 2020 proved to be one of the most difficult years in recent history. The devastating impact of COVID-19 on societies and economies intensified existing challenges, such as in quality and poverty. And in times of crisis,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot